Concepedia

Eculizumab for Treatment of Rapidly Progressive C3 Glomerulopathy

Moglie Le Quintrec, Arnaud Lionet, Christine Kandel, Franck Bourdon, Viviane Gnemmi, Magali Colombat, Jean‐Michel Goujon, Véronique Frémeaux‐Bacchi, Fádi Fakhouri

American Journal of Kidney Diseases · 2014 · 103 citations · 13 references

DOI

Concepts

References

13

C3 glomerulopathy: consensus report

Matthew C. Pickering, Vivette D. D’Agati, Carla Nester et al. · Kidney International · 2013 · 641 citations · Full text

, , +17

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

Aude Servais, Laure‐Hélène Noël, Lubka T. Roumenina et al. · Kidney International · 2012 · 567 citations

, , +17

Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H

Matthew C. Pickering, H. Terence Cook, Joanna Warren et al. · Nature Genetics · 2002 · 506 citations

, , +17

Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis

Andrew S. Bomback, Richard J. Smith, Gaetano R. Barile et al. · Clinical Journal of the American Society of Nephrology · 2012 · 362 citations

, , +17

C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up

Sanjeev Sethi, Fernando C. Fervenza, Yuzhou Zhang et al. · Kidney International · 2012 · 297 citations · Full text

, , +17